Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy

Francesco Piva, Matteo Giulietti, Matteo Santoni, Giulia Occhipinti, Marina Scarpelli, Antonio Lopez-Beltran, Liang Cheng, Giovanni Principato, Rodolfo Montironi

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Epithelial-to-mesenchymal transition (EMT) is a developmentally vital reversible process by which fully differentiated cells lose their epithelial features and acquire a migratory mesenchymal phenotype. EMT contributes to the metastatic potential of tumors. The expression profile and other biological properties of EMT suggest potential targets for cancer therapy, including in renal-cell carcinoma (RCC). The preclinical and clinical results have substantiated the promises that dysregulated elements leading to EMT can be a potential target in RCC patients. In this study, we illustrated the pathogenic and prognostic role of EMT in RCC. In addition, we reconstructed, by literature analysis, the different pathways implicated in the EMT process, thus supporting the rational for future EMT-directed therapeutic approaches for RCC patients.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalMolecular Diagnosis and Therapy
DOIs
StateAccepted/In press - Mar 3 2016

Fingerprint

Epithelial-Mesenchymal Transition
Renal Cell Carcinoma
Neoplasms
Therapeutics
Phenotype

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine
  • Medicine(all)
  • Pharmacology

Cite this

Piva, F., Giulietti, M., Santoni, M., Occhipinti, G., Scarpelli, M., Lopez-Beltran, A., ... Montironi, R. (Accepted/In press). Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy. Molecular Diagnosis and Therapy, 1-7. https://doi.org/10.1007/s40291-016-0192-5

Epithelial to Mesenchymal Transition in Renal Cell Carcinoma : Implications for Cancer Therapy. / Piva, Francesco; Giulietti, Matteo; Santoni, Matteo; Occhipinti, Giulia; Scarpelli, Marina; Lopez-Beltran, Antonio; Cheng, Liang; Principato, Giovanni; Montironi, Rodolfo.

In: Molecular Diagnosis and Therapy, 03.03.2016, p. 1-7.

Research output: Contribution to journalArticle

Piva, F, Giulietti, M, Santoni, M, Occhipinti, G, Scarpelli, M, Lopez-Beltran, A, Cheng, L, Principato, G & Montironi, R 2016, 'Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy', Molecular Diagnosis and Therapy, pp. 1-7. https://doi.org/10.1007/s40291-016-0192-5
Piva, Francesco ; Giulietti, Matteo ; Santoni, Matteo ; Occhipinti, Giulia ; Scarpelli, Marina ; Lopez-Beltran, Antonio ; Cheng, Liang ; Principato, Giovanni ; Montironi, Rodolfo. / Epithelial to Mesenchymal Transition in Renal Cell Carcinoma : Implications for Cancer Therapy. In: Molecular Diagnosis and Therapy. 2016 ; pp. 1-7.
@article{f276cb85a4314aada6e024b915ad1b5e,
title = "Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy",
abstract = "Epithelial-to-mesenchymal transition (EMT) is a developmentally vital reversible process by which fully differentiated cells lose their epithelial features and acquire a migratory mesenchymal phenotype. EMT contributes to the metastatic potential of tumors. The expression profile and other biological properties of EMT suggest potential targets for cancer therapy, including in renal-cell carcinoma (RCC). The preclinical and clinical results have substantiated the promises that dysregulated elements leading to EMT can be a potential target in RCC patients. In this study, we illustrated the pathogenic and prognostic role of EMT in RCC. In addition, we reconstructed, by literature analysis, the different pathways implicated in the EMT process, thus supporting the rational for future EMT-directed therapeutic approaches for RCC patients.",
author = "Francesco Piva and Matteo Giulietti and Matteo Santoni and Giulia Occhipinti and Marina Scarpelli and Antonio Lopez-Beltran and Liang Cheng and Giovanni Principato and Rodolfo Montironi",
year = "2016",
month = "3",
day = "3",
doi = "10.1007/s40291-016-0192-5",
language = "English (US)",
pages = "1--7",
journal = "Molecular Diagnosis and Therapy",
issn = "1177-1062",
publisher = "Adis International Ltd",

}

TY - JOUR

T1 - Epithelial to Mesenchymal Transition in Renal Cell Carcinoma

T2 - Implications for Cancer Therapy

AU - Piva, Francesco

AU - Giulietti, Matteo

AU - Santoni, Matteo

AU - Occhipinti, Giulia

AU - Scarpelli, Marina

AU - Lopez-Beltran, Antonio

AU - Cheng, Liang

AU - Principato, Giovanni

AU - Montironi, Rodolfo

PY - 2016/3/3

Y1 - 2016/3/3

N2 - Epithelial-to-mesenchymal transition (EMT) is a developmentally vital reversible process by which fully differentiated cells lose their epithelial features and acquire a migratory mesenchymal phenotype. EMT contributes to the metastatic potential of tumors. The expression profile and other biological properties of EMT suggest potential targets for cancer therapy, including in renal-cell carcinoma (RCC). The preclinical and clinical results have substantiated the promises that dysregulated elements leading to EMT can be a potential target in RCC patients. In this study, we illustrated the pathogenic and prognostic role of EMT in RCC. In addition, we reconstructed, by literature analysis, the different pathways implicated in the EMT process, thus supporting the rational for future EMT-directed therapeutic approaches for RCC patients.

AB - Epithelial-to-mesenchymal transition (EMT) is a developmentally vital reversible process by which fully differentiated cells lose their epithelial features and acquire a migratory mesenchymal phenotype. EMT contributes to the metastatic potential of tumors. The expression profile and other biological properties of EMT suggest potential targets for cancer therapy, including in renal-cell carcinoma (RCC). The preclinical and clinical results have substantiated the promises that dysregulated elements leading to EMT can be a potential target in RCC patients. In this study, we illustrated the pathogenic and prognostic role of EMT in RCC. In addition, we reconstructed, by literature analysis, the different pathways implicated in the EMT process, thus supporting the rational for future EMT-directed therapeutic approaches for RCC patients.

UR - http://www.scopus.com/inward/record.url?scp=84960145229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960145229&partnerID=8YFLogxK

U2 - 10.1007/s40291-016-0192-5

DO - 10.1007/s40291-016-0192-5

M3 - Article

C2 - 26940073

AN - SCOPUS:84960145229

SP - 1

EP - 7

JO - Molecular Diagnosis and Therapy

JF - Molecular Diagnosis and Therapy

SN - 1177-1062

ER -